跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
黃 唯誠
主治醫師
,
臺北醫學大學附設醫院
https://orcid.org/0000-0002-0327-8708
電子郵件
221005
h.tmu.edu
tw
h-index
105
引文
6
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
2015
2024
每年研究成果
概覽
指紋
網路
研究成果
(12)
類似的個人檔案
(6)
指紋
查看啟用 Wei-Cheng Huang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Mouse
100%
Pterostilbene
95%
Rutaecarpine
95%
Hydroxyl Radical
68%
Inducible Nitric Oxide Synthase
64%
Mitogen Activated Protein Kinase
58%
Brain Ischemia
53%
Tetradium ruticarpum
52%
Coumarin
52%
Thrombosis
52%
Terpene
47%
Integrin
47%
Ruthenium Complex
47%
Elizabethkingia
47%
Auraptene
47%
Anticoagulant Agent
47%
Anti-Inflammatory Drug
47%
Lipoteichoic Acid
47%
Lipopolysaccharide
47%
Immunosuppressive Agent
47%
Liver Injury
47%
Columbianadin
47%
Transcription Factors
47%
Minocycline
47%
Cyclic Nucleotide
47%
Immunoglobulin Enhancer Binding Protein
35%
Transcription Factor Nrf2
35%
Cyclooxygenase 2
28%
Nitric Oxide
28%
Tuberculosis
23%
Heme Oxygenase 1
23%
Middle Cerebral Artery Occlusion
23%
Nervous System Inflammation
23%
Graft Rejection
23%
Extrapulmonary Tuberculosis
23%
Graft Failure
23%
Tuberculostatic Agent
23%
Latent Tuberculosis
23%
Miliary Tuberculosis
23%
Antiplatelet
22%
Tumor Necrosis Factor
21%
Disease
20%
Antioxidant
17%
Combination Therapy
17%
Phosphotransferase
17%
Interleukin 1
16%
Antiinflammatory Activity
16%
Neuroprotection
16%
Cardiovascular Disease
14%
Edema
11%
Medicine and Dentistry
Terpene
95%
MAPK Signaling
95%
Auraptene
95%
Inflammatory Mediator
95%
Coumarin
95%
Signal Transduction
95%
Elizabethkingia
47%
Lipoteichoic Acid
47%
Transplantation
47%
Endoscopic Hemostasis
47%
Duodenum Hematoma
47%
Solid Organ Transplantation
47%
In Vitro
47%
4 Iodo 2,5 Dimethoxyamphetamine
47%
Complementary and Alternative Medicine
47%
Minocycline
47%
Morphinan
47%
Pylorus Stenosis
19%
Cholestasis
19%
Disease
15%
Combination Therapy
15%
Phosphotransferase
11%
Interleukin 1
11%
Tumor Necrosis Factor
11%
Catalase
11%
Antioxidant
11%
Amino Terminal Sequence
11%
Immunoglobulin Enhancer Binding Protein
11%
Antiinflammatory Activity
11%
Inducible Nitric Oxide Synthase
11%
Nitric Oxide
11%
Monotherapy
11%
Rifampicin
11%
Immunosuppressant
11%
Duodenum
9%
Acute Pancreatitis
9%
Duodenal Ulcer Bleeding
9%
Gastrointestinal Bleeding
9%
Esophagus
9%
Case Presentation
9%
Abdominal Pain
9%
Warfarin
9%
Pancreatitis
9%
Valve Replacement
9%
Hypotension
9%
3 Methylbenzoic Acid
7%
Tuberculosis
5%
Glutathione
5%
Native Polyacrylamide Gel Electrophoresis
5%
Malignant Neoplasm
5%